DUX4 and facioscapulohumeral muscular dystrophy: To further examine the effect of such targeting on DUX4 target genes in clinically relevant cell types, we carried out subsequent experiments in an hTERT-immortalized FSHD myoblast cell line22 with the aim of validating our initial findings in a clinically relevant setting.